As of April 16, 2025, Paul Hartmann (PHH2.F) has a market cap of $0.94 billion USD. According to our data, Paul Hartmann is ranked No.5113 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.94 B |
6.82%
|
Dec 30, 2024 | $0.88 B |
11.07%
|
Dec 29, 2023 | $0.80 B |
2.62%
|
Dec 30, 2022 | $0.77 B |
-36.70%
|
Dec 30, 2021 | $1.22 B |
-3.38%
|
Dec 30, 2020 | $1.27 B |
28.99%
|
Dec 30, 2019 | $0.98 B |
-1.21%
|
Dec 28, 2018 | $0.99 B |
-28.26%
|
Dec 29, 2017 | $1.39 B |
7.84%
|
Dec 30, 2016 | $1.28 B |
-7.62%
|
Dec 30, 2015 | $1.39 B |
37.64%
|
Dec 30, 2014 | $1.01 B |
23.15%
|
Dec 30, 2013 | $0.82 B |
22.19%
|
Dec 28, 2012 | $0.67 B |
22.63%
|
Dec 30, 2011 | $0.55 B |
-19.20%
|
Dec 30, 2010 | $0.68 B |
46.85%
|
Dec 30, 2009 | $0.46 B |
5.71%
|
Dec 30, 2008 | $0.44 B |
-1.62%
|
Dec 28, 2007 | $0.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Medtronic
MDT
|
$105.64 B |
0.002 M
|
![]() Ireland
|
![]() Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
![]() USA
|
![]() Cardinal Health
CAH
|
$32.43 B |
-0.000 M
|
![]() USA
|
![]() Baxter
BAX
|
$14.26 B |
0.000 M
|
![]() USA
|
![]() 3M
MMM
|
$72.95 B |
0.002 M
|
![]() USA
|
![]() Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
![]() USA
|
![]() Boston Scientific
BSX
|
$139.37 B |
0.007 M
|
![]() USA
|
![]() Zimmer Biomet
ZBH
|
$19.24 B |
0.000 M
|
![]() USA
|
![]() Hologic
HOLX
|
$13.06 B |
0.000 M
|
![]() USA
|
![]() Danaher
DHR
|
$135.88 B |
0.003 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Philips
PHG
|
$22.04 B |
-0.001 M
|
![]() Netherlands
|
![]() Fresenius Medical Care
FMS
|
$14.70 B |
22.409 M
|
![]() Germany
|
Market Cap | = | PHH2.F Stock Price | * | PHH2.F Shares Outstanding |
= | $265.63 | * | 3.55 M | |
= | $0.94 B |